Erratum: Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target (Journal of Clinical Endocrinology and Metabolism (2010) 95 (5338-5347) DOI:10.1210/jc.2010-1421)

L. A. Marlow, J. D'Innocenzi, Y. Zhang, S. D. Rohl, S. J. Cooper, T. Sebo, C. Grant, B. McIver, Jan Kasperbauer, J. T. Wadsworth, J. D. Casler, P. W. Kennedy, W Edward Jr. Highsmith, O. Clark, D. Milosevic, B. Netzel, K. Cradic, S. Arora, C. Beaudry, S. K. GrebeM. L. Silverberg, D. O. Azorsa, Robert Christian Smallridge, John A III Copland

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)4546
Number of pages1
JournalJournal of Clinical Endocrinology and Metabolism
Volume98
Issue number11
DOIs
StatePublished - Nov 1 2013

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Marlow, L. A., D'Innocenzi, J., Zhang, Y., Rohl, S. D., Cooper, S. J., Sebo, T., Grant, C., McIver, B., Kasperbauer, J., Wadsworth, J. T., Casler, J. D., Kennedy, P. W., Highsmith, W. E. J., Clark, O., Milosevic, D., Netzel, B., Cradic, K., Arora, S., Beaudry, C., ... Copland, J. A. III. (2013). Erratum: Detailed molecular fingerprinting of four new anaplastic thyroid carcinoma cell lines and their use for verification of RhoB as a molecular therapeutic target (Journal of Clinical Endocrinology and Metabolism (2010) 95 (5338-5347) DOI:10.1210/jc.2010-1421). Journal of Clinical Endocrinology and Metabolism, 98(11), 4546. https://doi.org/10.1210/jc.2013-3548